Company Filing History:
1 out of 3 
1 out of 832,812 Years Active: 1993-1995
Title: Richard T Ellison, III: Innovator in Diagnostic Testing
Introduction
Richard T Ellison, III, located in Denver, CO, is an accomplished inventor recognized for his significant contributions in the field of immunology and diagnostics. With a total of two patents to his name, Ellison has focused on developing solutions to enhance the detection and understanding of Campylobacter infections, which are critical for public health.
Latest Patents
Ellison's latest patents involve groundbreaking advancements in the creation of diagnostic tools and vaccines targeting Campylobacter jejuni and Campylobacter coli. One of his notable patents, titled "Antisera against a PEB1 antigen from Campylobacter jejuni," presents an antigenic composition that includes antigens derived from Campylobacter jejuni. This composition can be utilized as a vaccine to stimulate protective antibody production against both Campylobacter species. Additionally, this patent also encompasses diagnostic detection kits that utilize the novel antigenic composition or specific antisera for the identification of infections caused by these pathogens.
His other patent, which focuses on "Diagnostic testing for Campylobacter jejuni or Campylobacter coli," describes a set of antigenic compositions for the diagnostic assessment of these infections. This involves a PEB1 antigen with a defined molecular weight and isoelectric point, as well as the PEB3 antigen, which are crucial for effective diagnostic testing.
Career Highlights
Throughout his career, Ellison has worked with various institutions, including Enteric Research Laboratories Inc., where he has contributed to significant research in the microbiological domain. His efforts have greatly advanced the understanding of bacterial pathogens and how they affect human health.
Collaborations
Ellison has collaborated with notable scientists, including Martin J Blaser and Zhi H Pei. These partnerships have fostered innovative research and development in the field of microbial diagnostics and vaccine discovery.
Conclusion
Richard T Ellison, III stands out as a significant figure in the realm of medical innovation, with his inventions paving the way for improved diagnostics and preventive measures against Campylobacter infections. His commitment to research and collaboration continues to influence the field and contributes to better public health outcomes.